SCHEMBL9119474

SCHEMBL9119474

O=C(c1ccccc1)c1cccc2c1NCCO2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
RAB9A P51151 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
TP53 P04637 2/20 0.43
LMNA P02545 1/20 0.43
CASP1 P29466 1/20 0.43
NPC1 O15118 1/20 0.42
AKR1C3 P42330 1/20 0.42
GAA P10253 3/20 0.41
MAPT P10636 3/20 0.41
NPSR1 Q6W5P4 2/20 0.41
CYP1A2 P05177 2/20 0.40
CYP2C9 P11712 2/20 0.40
POLB P06746 1/20 0.40
THRB P10828 1/20 0.40
CYP2C19 P33261 1/20 0.40
CYP3A4 P08684 1/20 0.40
GLA P06280 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15621991 0.85 POLB (0.49) ALDH1A1RAB9ASMN1; SMN2LMNACASP1
SCHEMBL749535 0.84 ALOX5 (0.46) ALDH1A1SMN1; SMN2CYP2C9
SCHEMBL29804911 0.84 ALOX5 (0.46) ALDH1A1SMN1; SMN2CYP2C9
SCHEMBL13347539 0.84 MAPT (0.38) ALDH1A1SMN1; SMN2TP53LMNACASP1
SCHEMBL22607785 0.80 PARP1 (0.45) ALDH1A1MAPT
SCHEMBL9856069 0.77 HDAC11 (0.34) ALDH1A1SMN1; SMN2GAAMAPT
SCHEMBL30517094 0.77 ALOX5 (0.51) ALDH1A1RAB9ASMN1; SMN2TP53LMNA
SCHEMBL984368 0.77 ALOX5 (0.51) ALDH1A1RAB9ASMN1; SMN2TP53LMNA
SCHEMBL9225764 0.75 AKR1C3 (0.47) ALDH1A1RAB9ASMN1; SMN2AKR1C3GAA
SCHEMBL27343882 0.75 CTNNB1 (0.53) ALDH1A1RAB9ASMN1; SMN2TP53LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5461048-A Tricyclic compounds having cholecystokinin antagonist activity FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1995-10-24 US disclosed
US-5401737-A Tricyclic compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1995-03-28 US disclosed
EP-0360079-B1 Tricyclic compounds, processes for their preparation and pharmaceutical compositions comprising them FUJISAWA PHARMACEUTICAL CO (JP) 1994-02-02 EP disclosed
US-5248679-A Tricyclic compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-09-28 US disclosed
CN-1022187-C Method for preparation of tricyclic compounds FUJISAWA PHARMACEUTICAL CO (JP) 1993-09-22 CN disclosed
US-5155101-A Tricyclic compounds FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1992-10-13 US disclosed
US-4981847-A Tricyclic compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-01-01 US disclosed
CN-1040981-A Tricyclic compound FUJISAWA PHARMACEUTICAL CO (JP) 1990-04-04 CN disclosed
EP-0360079-A1 Tricyclic compounds, processes for their preparation and pharmaceutical compositions comprising them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-03-28 EP disclosed